Literature DB >> 33614494

MiR-21-5p Induces Pyroptosis in Colorectal Cancer via TGFBI.

Rilei Jiang1, Xiaolei Chen1, Shaohua Ge2, Qin Wang3, Yichang Liu2, Haijun Chen2, Jiatuo Xu1, Jiang Wu2.   

Abstract

Pyroptosis is a distinct form of programmed cell death in eukaryotic cells that has garnered increasing attention in cancer-related research. Moreover, although miR-21 has been reported as abnormally expressed in colorectal cancer, due to a lack of in-depth research on the transcriptional regulation mechanisms of miR-21, its clinical usage remains limited. Our study is the first, to our knowledge, to compare the clinical manifestations and laboratory phenotypes associated with miR-21-3p and miR-21-5p. Morphologically, the transfection of miR-21-3p or miR-21-5p inhibitors, as well as miR-21-5p mimics into HCT-116 and HT-29 cell lines, induced cell death. Surprisingly, overexpression of miR-21-5p induced cell death more strongly than its knockdown. Mechanistic studies of miR-21-5p overexpression revealed that various inflammatory factors including IL-1β and IL-18 were released, while pyroptosis-associated mRNAs were upregulated and proteins were activated. Moreover, miR-21-5p was found to act as a downstream factor to significantly and directly regulate transforming growth factor beta-induced (TGFB1). Specifically, miR-21-5p overexpression caused downregulation of TGFBI, which may have led to pyroptosis. Collectively, we revealed that miR-21-5p induces pyroptosis in colorectal cancer via TGFBI regulation, thereby providing important mechanistic insights into its antitumor effects and expanding its potential for clinical applications.
Copyright © 2021 Jiang, Chen, Ge, Wang, Liu, Chen, Xu and Wu.

Entities:  

Keywords:  TGFBI; colorectal cancer; miR-21; programmed cell death; pyroptosis

Year:  2021        PMID: 33614494      PMCID: PMC7892456          DOI: 10.3389/fonc.2020.610545

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  5 in total

1.  METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.

Authors:  Kefan Ye; Lingchuan Li; Bao Wu; Dongjie Wang
Journal:  Genes Genomics       Date:  2022-09-08       Impact factor: 2.164

2.  Clinical role of miR-421 as a novel biomarker in diagnosis of gastric cancer patients: A meta-analysis.

Authors:  Yingying Xu; Guiping Wang; Wenqing Hu; Songbing He; Dandan Li; Ping Chen; Jinjie Zhang; Yongshun Gao; Duonan Yu; Liang Zong
Journal:  Medicine (Baltimore)       Date:  2022-05-13       Impact factor: 1.817

Review 3.  Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer.

Authors:  Liqing Lu; Ye Zhang; Xuemei Tan; Yulia Merkher; Sergey Leonov; Li Zhu; Yalan Deng; Huajun Zhang; Dandan Zhu; Yuying Tan; Ying Fu; Ting Liu; Yongheng Chen
Journal:  Cell Death Discov       Date:  2022-07-27

4.  Classification of pyroptosis patterns and construction of a novel prognostic model for prostate cancer based on bulk and single-cell RNA sequencing.

Authors:  Jianhan Fu; Guoqiang Li; Ruixiang Luo; Zhijie Lu; Yinhuai Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-29       Impact factor: 6.055

5.  Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression.

Authors:  Janson Tse; Thomas Pierce; Annalisa L E Carli; Mariah G Alorro; Stefan Thiem; Eric G Marcusson; Matthias Ernst; Michael Buchert
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.